PMID: 11242048

Choi JY, Muallem D, Kiselyov K, Lee MG, Thomas PJ, Muallem S
Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis.
Nature. 2001 Mar 1;410(6824):94-7., 2001-03-01 [PubMed]
Sentences
No. Mutations Sentence Comment
18 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:18:32
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:18:22
status: NEW
view ABCC7 p.Ile148Thr details
Two of the mutations, I148T and R117H, are relatively common, and thus the clinical data are solid. Login to comment
23 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:23:292
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:23:293
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:23:276
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:23:277
status: NEW
view ABCC7 p.Ile148Thr details
To validate the ability of this procedure to accurately report Cl-channel activity, we determined the correlation between expression ef®ciency (green ¯uorescent protein (GFP) ¯uorescence), Cl- current and changes in [Cl- ]i in cells transfected with CFTR, CFTR(I148T) and CFTR(R117H). Login to comment
24 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:445
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:449
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:466
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:470
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:533
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:537
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:622
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:626
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:652
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:656
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:688
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:692
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:885
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:24:889
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:437
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:441
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:458
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:462
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:539
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:543
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:616
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:620
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:640
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:644
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:682
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:686
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:875
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:24:879
status: NEW
view ABCC7 p.Ile148Thr details
Figure 1a±h shows that similar results are reported by measurement of Cl- current and [Cl- ]i for CFTR and the mutants. Therefore, the Cl-transport capacity of all other CFTR letters to nature 94 NATURE | VOL 410 | 1 MARCH 2001 |www.nature.com NO3 - NO3 - NO3 - Forskolin 5 µM Forskolin 5 µM Forskolin 5 µM Cl-free Forskolin 5 µM Cl-free Cl-free Forskolin 5 µM Forskolin 5 µM 0.25 pHunits 250 s e WT f I148T g R117H i WT j I148T k R117H 10mMCl- 200 s 0 0.2 0.4 [Cl- ]change (mMs-1 ) n=6 n=4 n=3 WT R117H I148T 0 0.2 0.4 0.6 0.8 1.0 HCO3 -transport (∆pH+ min-1 ) n=8 n=4 n=3 I148T R117H WT l a WT b I148T c d h R117H 0 8 16 24 n=5 n=4n=3 WT I148T R117H Current (pApF-1 perGFP fluorescence) 120 s 100pA For 5 µMFor 5 µMFor 5 µM Figure 1 cAMP-stimulated Cl- and HCO3 transport by wild-type (WT) CFTR and the CFTR mutants I148T and R117H. Login to comment
32 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:32:175
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:32:165
status: NEW
view ABCC7 p.Ile148Thr details
(c) 2001 Macmillan Magazines Ltd mutants was evaluated from changes in [Cl- ]i. Figure 1e±l shows the experimental protocols used to measure the effect of the I148T and R117H mutations on Cl- and HCO3 transport. Login to comment
33 ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:33:4
status: NEW
view ABCC7 p.Ile148Thr details
The I148T mutant is normally processed and mediates macroscopicCl- current(Fig.1d;ref.16),single-channelproperties16 and Cl- ¯uxes (Fig. 1h) indistinguishable from those of wild-type CFTR, but is associated with CF with pancreatic insuf®ciency. Login to comment
34 ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:34:115
status: NEW
view ABCC7 p.Ile148Thr details
Replacing external Cl- with NO3 in non-stimulated cells caused a slow Clef¯ux in cells expressing CFTR or the I148T mutant. Login to comment
36 ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 11242048:36:58
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 11242048:36:77
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Ser1255Pro
X
ABCC7 p.Ser1255Pro 11242048:36:66
status: NEW
view ABCC7 p.Ser1255Pro details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:36:36
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 11242048:36:50
status: NEW
view ABCC7 p.Ala1067Thr details
ABCC7 p.Gly178Arg
X
ABCC7 p.Gly178Arg 11242048:36:43
status: NEW
view ABCC7 p.Gly178Arg details
Similar rates were measured for the I148T, G178R, A1067T, G1244E, S1255P and G1349D mutants (see Fig. 3 for location of these mutations in CFTR), all of which are associated with CF with pancreatic insuf®- ciency. Login to comment
44 ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:44:16
status: NEW
view ABCC7 p.Ile148Thr details
Results for the I148T mutant are shown in Fig. 1, and the averaged results for all mutants are listed in Table 1 in the Supplementary Information. Login to comment
46 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:46:30
status: NEW
view ABCC7 p.Arg117His details
The results obtained with the R117H mutation are illustrated in Fig. 1. Login to comment
47 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:47:162
status: NEW
view ABCC7 p.Arg117His details
In sharp contrast with the results obtained with the mutants associated with CF with pancreatic insuf®ciency, and in agreement with previous reports25 , the R117H mutation reduced Cl- current and the MQAE response by about 70%. Login to comment
48 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:48:17
status: NEW
view ABCC7 p.Arg117His details
By contrast, the R117H mutation reduced the ability of CFTR to support HCO3 transport by only 37%. Login to comment
49 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 11242048:49:27
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Glu193Lys
X
ABCC7 p.Glu193Lys 11242048:49:4
status: NEW
view ABCC7 p.Glu193Lys details
ABCC7 p.Asp648Val
X
ABCC7 p.Asp648Val 11242048:49:11
status: NEW
view ABCC7 p.Asp648Val details
The E193K, D648V, H949Yand R1070Q mutants, all associated with CF with pancreatic suf®ciency, had no effect on Cl-transport but reduced HCO3 transport by 50±65%. Login to comment
50 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:50:49
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:50:59
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:50:79
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:50:69
status: NEW
view ABCC7 p.His620Gln details
Two sets of particularly interesting mutants are G551D and G551S and H620Q and A800G. Login to comment
51 ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:51:0
status: NEW
view ABCC7 p.Gly551Ser details
G551S, which is associated with CF with pancreatic suf®ciency, had no effect on Cl-transport but reduced HCO3 transport by 59% (Fig. 2). Login to comment
52 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:52:33
status: NEW
view ABCC7 p.Gly551Asp details
As reported previously17,18,26 , G551D reduced Cl-transport to 53% of the control value. Login to comment
54 ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:54:41
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:54:31
status: NEW
view ABCC7 p.His620Gln details
When expressed in oocytes, the H620Q and A800G mutants increased the macroscopic Cl- current about threefold and the channel open probability by 150±180% (ref. 19). Login to comment
56 ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:56:52
status: NEW
view ABCC7 p.Ala800Gly details
Despite these markedly enhanced Cl- ¯uxes, the A800G mutation, which causes CF with pancreatic suf®ciency, only stimulated HCO3 transport to 75% of the wild-type CFTR value. Login to comment
57 ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:57:4
status: NEW
view ABCC7 p.His620Gln details
The H620Q mutant, found in one CF patient with pancreatic insuf®ciency, only stimulated HCO3 transport about 13% as effectively as did CFTR. Login to comment
60 ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 11242048:60:21
status: NEW
view ABCC7 p.Arg1070Gln details
In this respect, the R1070Q mutation, in the few documented cases, has been found to be associated with CF with either pancreatic suf®ciency or pancreatic insuf®ciency. Login to comment
66 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:66:186
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:66:345
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:66:346
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:66:451
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:66:452
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:66:522
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:66:523
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:66:178
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:66:337
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:66:338
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:66:457
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:66:458
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:66:528
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:66:529
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:66:268
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:66:411
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:66:412
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:66:445
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:66:446
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:66:516
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:66:517
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:66:260
status: NEW
view ABCC7 p.His620Gln details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:66:276
status: NEW
view ABCC7 p.His620Gln details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:66:439
status: NEW
view ABCC7 p.His620Gln details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:66:440
status: NEW
view ABCC7 p.His620Gln details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:66:510
status: NEW
view ABCC7 p.His620Gln details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:66:511
status: NEW
view ABCC7 p.His620Gln details
Notably, although a few of these mutants exhibit altered letters to nature NATURE |VOL 410 |1 MARCH 2001 |www.nature.com 95 NO3 - Forskolin 5 µM NO3 - Forskolin 5 µM a G551S b G551D 10mMCl- 200 s NO3 - NO3 - Forskolin 5 µM Forskolin 5 µM f H620Q g A800G h H620Q Forskolin 5 µMCl- free Cl- freeCl- free Cl-free c G551S d G551D Forskolin 5 µM Forskolin 5 µM 0.25pHunits 250 s e A800G 0 0.25 0.50 0.75 1.00 H620Q A800G G551D G551S j WT Forskolin 5 µM 0 0.25 0.50 0.75 1.00 H620Q A800G G551D G551S WT i [Cl- ]change(mMs-1 )HCO3 -transport (∆pH+ min-1 ) Figure 2 cAMP-stimulated Cl- and HCO3 transport by CFTR mutants associated with a severe or a mild form of CF. Login to comment
70 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:70:29
status: NEW
view ABCC7 p.Arg117His details
In this regard, although the R117H mutation markedly reduces Cl-channel activity and Cl-transport (Fig. 1), it is associated with a mild form of CF, probably because it supports substantial HCO3 transport (Fig. 1). Login to comment
155 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:155:89
status: NEW
view ABCC7 p.Gly551Asp details
Illek, B. et al. Defective function of the cystic ®brosis-causing missense mutation G551D is recovered by genistein. Login to comment
186 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:186:136
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11242048:186:370
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11242048:186:291
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:186:188
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly551Ser
X
ABCC7 p.Gly551Ser 11242048:186:376
status: NEW
view ABCC7 p.Gly551Ser details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 11242048:186:161
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 11242048:186:311
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 11242048:186:175
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 11242048:186:325
status: NEW
view ABCC7 p.Gly1349Asp details
ABCC7 p.Ser1255Pro
X
ABCC7 p.Ser1255Pro 11242048:186:168
status: NEW
view ABCC7 p.Ser1255Pro details
ABCC7 p.Ser1255Pro
X
ABCC7 p.Ser1255Pro 11242048:186:318
status: NEW
view ABCC7 p.Ser1255Pro details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 11242048:186:118
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 11242048:186:206
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Arg1070Gln
X
ABCC7 p.Arg1070Gln 11242048:186:304
status: NEW
view ABCC7 p.Arg1070Gln details
ABCC7 p.Gly970Arg
X
ABCC7 p.Gly970Arg 11242048:186:148
status: NEW
view ABCC7 p.Gly970Arg details
ABCC7 p.Gly970Arg
X
ABCC7 p.Gly970Arg 11242048:186:346
status: NEW
view ABCC7 p.Gly970Arg details
ABCC7 p.His949Tyr
X
ABCC7 p.His949Tyr 11242048:186:200
status: NEW
view ABCC7 p.His949Tyr details
ABCC7 p.His949Tyr
X
ABCC7 p.His949Tyr 11242048:186:340
status: NEW
view ABCC7 p.His949Tyr details
ABCC7 p.Arg297Gln
X
ABCC7 p.Arg297Gln 11242048:186:130
status: NEW
view ABCC7 p.Arg297Gln details
ABCC7 p.Arg297Gln
X
ABCC7 p.Arg297Gln 11242048:186:285
status: NEW
view ABCC7 p.Arg297Gln details
ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:186:194
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.Ala800Gly
X
ABCC7 p.Ala800Gly 11242048:186:394
status: NEW
view ABCC7 p.Ala800Gly details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 11242048:186:154
status: NEW
view ABCC7 p.Ala1067Thr details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 11242048:186:297
status: NEW
view ABCC7 p.Ala1067Thr details
ABCC7 p.Gly178Arg
X
ABCC7 p.Gly178Arg 11242048:186:124
status: NEW
view ABCC7 p.Gly178Arg details
ABCC7 p.Gly178Arg
X
ABCC7 p.Gly178Arg 11242048:186:273
status: NEW
view ABCC7 p.Gly178Arg details
ABCC7 p.Glu193Lys
X
ABCC7 p.Glu193Lys 11242048:186:182
status: NEW
view ABCC7 p.Glu193Lys details
ABCC7 p.Glu193Lys
X
ABCC7 p.Glu193Lys 11242048:186:279
status: NEW
view ABCC7 p.Glu193Lys details
ABCC7 p.Asp648Val
X
ABCC7 p.Asp648Val 11242048:186:388
status: NEW
view ABCC7 p.Asp648Val details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:186:142
status: NEW
view ABCC7 p.His620Gln details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 11242048:186:382
status: NEW
view ABCC7 p.His620Gln details
letters to nature 96 NATURE |VOL 410 |1 MARCH 2001 |www.nature.com HCO3 -/Cl- transportratio 0 0.25 0.50 0.75 1.00 WT I148T G178R R297Q G551D H620Q G970R A1067T G1244E S1255P G1349D E193K G551S A800G H949Y R1070Q Pancreatic insufficient Pancreatic sufficientD648V N CI148T G178R E193K R297Q R117H A1067T R1070Q G1244E S1255P G1349D NBD2 RD H949Y G970R CL4CL3CL2CL1 NBD1 G551D G551S H620Q D648V A800G Figure 3 The HCO3:Cl-transport ratio of CFTR mutants associated with CF. Login to comment
212 ABCC7 p.Gly970Arg
X
ABCC7 p.Gly970Arg 11242048:212:95
status: NEW
view ABCC7 p.Gly970Arg details
Acknowledgements We thank H. Cuppens from the European CF Consortium for informing us that the G970R mutation results in pancreatic insuf®ciency. Login to comment